Thanks to all who attended the CU Anschutz Innovation Forum
CU Innovations, Startup Toolbox and Academia Industry Alliance (AIA) hosted a 3-day event on June 10-12th that highlighted the diversity of innovation at the University of Colorado Anschutz Medical Campus.
Engaging presentations and panel discussions demystified the innovation journey. Key sessions covered company formation, building inclusive teams and career opportunities. CU researchers, start-ups and industry partners participated and networked at this successful event!
Congratulations to the winners of the Venture Showcase: NowVitals, pitched by Robin Deterding, MD, and Vināśa Oncology, pitched by Sujatha Venkataraman, PhD!
(1/19)
(2/19)
(3/19)
(4/19)
(5/19)
(6/19)
(7/19)
(8/19)
(9/19)
(10/19)
(11/19)
(12/19)
(13/19)
(14/19)
(15/19)
(16/19)
(17/19)
(18/19)
(19/19)
Agenda
Building upon the success of last year's Stories of Women-Led Innovation Event, this forum continued highlighting the achievements and challenges faced by our women innovators and demystifying the innovation pathway through presentations and panel discussions. Sessions covered intellectual property protection, building inclusive teams and addressing bias in the context of academic innovation.
Attendees were excited to hear from our keynote speaker, Gitanjali Rao, aspiring scientist, inventor and author!
Joseph Mikulin PhD
Laboratory Director, HemoGenix
Joe graduated with his Ph.D. in Microbiology from Miami University in 2022 and worked for MIMEDX as a Research Scientist investigating the immunomodulatory effects of human placental allografts during wound healing. Now he’s the Laboratory Director of HemoGenix, conducting studies to determine the effects of test compounds on characteristics of various stem cell populations.
Joseph Mikulin PhD
Laboratory Director, HemoGenix
Joe graduated with his Ph.D. in Microbiology from Miami University in 2022 and worked for MIMEDX as a Research Scientist investigating the immunomodulatory effects of human placental allografts during wound healing. Now he’s the Laboratory Director of HemoGenix, conducting studies to determine the effects of test compounds on characteristics of various stem cell populations.
Joseph Mikulin PhD
Laboratory Director, HemoGenix
Joe graduated with his Ph.D. in Microbiology from Miami University in 2022 and worked for MIMEDX as a Research Scientist investigating the immunomodulatory effects of human placental allografts during wound healing. Now he’s the Laboratory Director of HemoGenix, conducting studies to determine the effects of test compounds on characteristics of various stem cell populations.
Joseph Mikulin PhD
Laboratory Director, HemoGenix
Joe graduated with his Ph.D. in Microbiology from Miami University in 2022 and worked for MIMEDX as a Research Scientist investigating the immunomodulatory effects of human placental allografts during wound healing. Now he’s the Laboratory Director of HemoGenix, conducting studies to determine the effects of test compounds on characteristics of various stem cell populations.
Joseph Mikulin PhD
Laboratory Director, HemoGenix
Joe graduated with his Ph.D. in Microbiology from Miami University in 2022 and worked for MIMEDX as a Research Scientist investigating the immunomodulatory effects of human placental allografts during wound healing. Now he’s the Laboratory Director of HemoGenix, conducting studies to determine the effects of test compounds on characteristics of various stem cell populations.
Joseph Mikulin PhD
Laboratory Director, HemoGenix
Joe graduated with his Ph.D. in Microbiology from Miami University in 2022 and worked for MIMEDX as a Research Scientist investigating the immunomodulatory effects of human placental allografts during wound healing. Now he’s the Laboratory Director of HemoGenix, conducting studies to determine the effects of test compounds on characteristics of various stem cell populations.
Joseph Mikulin PhD
Laboratory Director, HemoGenix
Joe graduated with his Ph.D. in Microbiology from Miami University in 2022 and worked for MIMEDX as a Research Scientist investigating the immunomodulatory effects of human placental allografts during wound healing. Now he’s the Laboratory Director of HemoGenix, conducting studies to determine the effects of test compounds on characteristics of various stem cell populations.
This event aimed to educate and inspire entrepreneurs at all stages. Featuring panels on company formation, funding biomedical discoveries and creating strategic alliances, each session included interactive elements and the chance to network with potential partners from the Anschutz campus and beyond.
Attendees got to know Jodie Morrison, CEO of Q32 Bio, and Kimberly Muller, Executive Director of CU Innovations, through their Fireside Chat Keynote.
Joseph Mikulin PhD
Laboratory Director, HemoGenix
Joe graduated with his Ph.D. in Microbiology from Miami University in 2022 and worked for MIMEDX as a Research Scientist investigating the immunomodulatory effects of human placental allografts during wound healing. Now he’s the Laboratory Director of HemoGenix, conducting studies to determine the effects of test compounds on characteristics of various stem cell populations.
Joseph Mikulin PhD
Laboratory Director, HemoGenix
Joe graduated with his Ph.D. in Microbiology from Miami University in 2022 and worked for MIMEDX as a Research Scientist investigating the immunomodulatory effects of human placental allografts during wound healing. Now he’s the Laboratory Director of HemoGenix, conducting studies to determine the effects of test compounds on characteristics of various stem cell populations.
Joseph Mikulin PhD
Laboratory Director, HemoGenix
Joe graduated with his Ph.D. in Microbiology from Miami University in 2022 and worked for MIMEDX as a Research Scientist investigating the immunomodulatory effects of human placental allografts during wound healing. Now he’s the Laboratory Director of HemoGenix, conducting studies to determine the effects of test compounds on characteristics of various stem cell populations.
Joe graduated with his Ph.D. in Microbiology from Miami University in 2022 and worked for MIMEDX as a Research Scientist investigating the immunomodulatory effects of human placental allografts during wound healing. Now he’s the Laboratory Director of HemoGenix, conducting studies to determine the effects of test compounds on characteristics of various stem cell populations.
Joseph Mikulin PhD
Laboratory Director, HemoGenix
Joe graduated with his Ph.D. in Microbiology from Miami University in 2022 and worked for MIMEDX as a Research Scientist investigating the immunomodulatory effects of human placental allografts during wound healing. Now he’s the Laboratory Director of HemoGenix, conducting studies to determine the effects of test compounds on characteristics of various stem cell populations.
Joseph Mikulin PhD
Laboratory Director, HemoGenix
Joe graduated with his Ph.D. in Microbiology from Miami University in 2022 and worked for MIMEDX as a Research Scientist investigating the immunomodulatory effects of human placental allografts during wound healing. Now he’s the Laboratory Director of HemoGenix, conducting studies to determine the effects of test compounds on characteristics of various stem cell populations.
Congratulations to the judge vote winner, NowVitals pitched by Robin Deterding, MD, and the audience vote winner, Vināśa Oncology pitched by Sujatha Venkataraman, PhD!
Joseph Mikulin PhD
Laboratory Director, HemoGenix
Joe graduated with his Ph.D. in Microbiology from Miami University in 2022 and worked for MIMEDX as a Research Scientist investigating the immunomodulatory effects of human placental allografts during wound healing. Now he’s the Laboratory Director of HemoGenix, conducting studies to determine the effects of test compounds on characteristics of various stem cell populations.
Joseph Mikulin PhD
Laboratory Director, HemoGenix
Joe graduated with his Ph.D. in Microbiology from Miami University in 2022 and worked for MIMEDX as a Research Scientist investigating the immunomodulatory effects of human placental allografts during wound healing. Now he’s the Laboratory Director of HemoGenix, conducting studies to determine the effects of test compounds on characteristics of various stem cell populations.
With sessions featuring scientific talks, career panels, and a 2-hour networking lunch, RMBTS offered a prime platform to highlight scientific advancements and career opportunities, and foster collaboration within Colorado's scientific community.
Joseph Mikulin PhD
Laboratory Director, HemoGenix
Joe graduated with his Ph.D. in Microbiology from Miami University in 2022 and worked for MIMEDX as a Research Scientist investigating the immunomodulatory effects of human placental allografts during wound healing. Now he’s the Laboratory Director of HemoGenix, conducting studies to determine the effects of test compounds on characteristics of various stem cell populations.
Joseph Mikulin PhD
Laboratory Director, HemoGenix
Joe graduated with his Ph.D. in Microbiology from Miami University in 2022 and worked for MIMEDX as a Research Scientist investigating the immunomodulatory effects of human placental allografts during wound healing. Now he’s the Laboratory Director of HemoGenix, conducting studies to determine the effects of test compounds on characteristics of various stem cell populations.
Joseph Mikulin PhD
Laboratory Director, HemoGenix
Joe graduated with his Ph.D. in Microbiology from Miami University in 2022 and worked for MIMEDX as a Research Scientist investigating the immunomodulatory effects of human placental allografts during wound healing. Now he’s the Laboratory Director of HemoGenix, conducting studies to determine the effects of test compounds on characteristics of various stem cell populations.
Joseph Mikulin PhD
Laboratory Director, HemoGenix
Joe graduated with his Ph.D. in Microbiology from Miami University in 2022 and worked for MIMEDX as a Research Scientist investigating the immunomodulatory effects of human placental allografts during wound healing. Now he’s the Laboratory Director of HemoGenix, conducting studies to determine the effects of test compounds on characteristics of various stem cell populations.
Event Sponsors
Thank you to our sponsors for making this forum possible! We are greatly appreciative of your continued support.
PLATINUM SPONSORS:
SPONSORS:
